The angiotensin-converting enzyme gene family: genomics and pharmacology

Trends in Pharmacological Sciences
Anthony J Turner, Nigel M Hooper

Abstract

Modulation of the renin-angiotensin system (RAS), and particularly inhibition of angiotensin-converting enzyme (ACE), a zinc metallopeptidase, has long been a prime strategy in the treatment of hypertension. However, other angiotensin metabolites are gaining in importance as our understanding of the RAS increases. Recently, genomic approaches have identified the first human homologue of ACE, termed ACEH (or ACE2). ACEH differs in specificity and physiological roles from ACE, which opens a potential new area for discovery biology. The gene that encodes collectrin, a homologue of ACEH, is upregulated in response to renal injury. Collectrin lacks a catalytic domain, which indicates that there is more to ACE-like function than simple peptide hydrolysis.

References

Feb 1, 1991·Hypertension·K KoharaC M Ferrario
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M R EhlersJ F Riordan
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·F SoubrierP Corvol
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R A Skidgel, E G Erdös
Oct 1, 1985·Medicinal Research Reviews·M J Wyvratt, A A Patchett
Aug 21, 1970·Biochimica Et Biophysica Acta·H Y YangY Levin
Jan 1, 1994·Essays in Biochemistry·T Inagami
Jan 15, 1997·The Biochemical Journal·N M HooperA J Turner
May 15, 1997·The Journal of Clinical Investigation·C R EstherK E Bernstein
Nov 25, 1997·Brain Research. Brain Research Reviews·J W Wright, J W Harding
Jul 17, 1999·Trends in Endocrinology and Metabolism : TEM·E G ErdösB M Marcic
Aug 24, 1999·Hypertension·A J RoksW H van Gilst
Sep 30, 1999·Nature Medicine·D W Cushman, M A Ondetti
Feb 17, 2000·Annals of the New York Academy of Sciences·R E IsaacA D Shirras
Aug 30, 2000·Biochemical Society Transactions·N M Hooper, A J Turner
Feb 24, 2001·European Journal of Clinical Pharmacology·C MeuneC Caulin
Mar 10, 2001·Trends in Pharmacological Sciences·J Bralet, J C Schwartz
Mar 22, 2001·Journal of Neurochemistry·T MustafaA L Albiston
Apr 11, 2001·Clinical Science·D T DinhM E Fabiani

❮ Previous
Next ❯

Citations

Sep 22, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Keiji KubaJosef M Penninger
May 11, 2005·Cardiovascular Drugs and Therapy·Pasquale Pagliaro, Claudia Penna
Oct 6, 2007·Biological Trace Element Research·Satish Kumar Taneja, Reshu Mandal
Jul 13, 2005·Progress in Biophysics and Molecular Biology·Shant Der SarkissianMohan K Raizada
Mar 24, 2004·Trends in Genetics : TIG·Nobuyuki Takahashi, Oliver Smithies
Jun 1, 2005·Toxicon : Official Journal of the International Society on Toxinology·Mirian A F Hayashi, Antonio C M Camargo
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Nov 7, 2002·Current Biology : CB·Urs ErikssonJosef M Penninger
Apr 15, 2003·Trends in Cardiovascular Medicine·Gavin Y OuditJosef M Penninger
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·A H Jan Danser
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·David Coates
Nov 30, 2012·Journal of Agricultural and Food Chemistry·Ching-Ching LauNorhaniza Aminudin
Dec 12, 2003·Nature Reviews. Drug Discovery·K Ravi AcharyaMario R W Ehlers
Jun 18, 2002·Journal of Neurochemistry·Julie A Carson, Anthony J Turner
Dec 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jeeyon JeongDavid J Eide
May 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yoshitaka FujiharaMasaru Okabe
Oct 8, 2004·The British Journal of Nutrition·Vanessa VermeirssenWilly Verstraete
Apr 11, 2008·Journal of Biomolecular Structure & Dynamics·Martin SramkoMilan Remko
Apr 11, 2003·Diabetes Technology & Therapeutics·David W Moskowitz
Jul 14, 2011·Genetic Testing and Molecular Biomarkers·Sevgi YimeniciogluMehmet Yavuz Coskun
Nov 10, 2009·Pharmacogenetics and Genomics·Caroline F ThornRuss B Altman
Jul 16, 2003·Cold Spring Harbor Symposia on Quantitative Biology·S B GurleyT M Coffman
Mar 1, 2008·Clinical and Experimental Pharmacology & Physiology·A KoitkaC Tikellis
Aug 17, 2004·Journal of Virology·Tsanan GiroglouDorothee von Laer
Sep 2, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Marc F DoobayEric Lazartigues
Apr 27, 2012·International Journal of Peptides·Chris Tikellis, M C Thomas
Oct 19, 2006·Journal of Biomedicine & Biotechnology·Deng-Shun WangJames S Malter
Aug 1, 2006·The Journal of Clinical Investigation·Susan B GurleyThomas M Coffman
Aug 14, 2003·Genome Biology·James F Riordan
Mar 10, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Jun AgataKazuaki Shimamoto
Nov 13, 2012·European Journal of Endocrinology·Se Eun ParkByung-Soo Youn
Aug 28, 2012·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Günter Müller
Aug 21, 2014·BioMed Research International·Cheng-Liang XieYeung-Joon Choi
Jul 17, 2014·Journal of Cell Communication and Signaling·Charlotte Harrison, K Ravi Acharya

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.